Press Releases Alpha Tau Medical Ltd.

Equities

DRTS

IL0011839383

Market Closed - Nasdaq Other stock markets 21:30:00 15/05/2024 BST			5-day change	1st Jan Change
2.65 ^USD	+0.61%		+9.96%	-11.96%

05-06	Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow	CI
03-07	Alpha Tau Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer	05-13	GL
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer	05-13	AQ
Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow	05-06	AQ
Alpha Tau to Participate in May Investor Conferences	05-01	AQ
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit	03-25	AQ
Alpha Tau Medical : to Present at the Jefferies Radiopharma Innovation Summit - Form 6-K	03-25	PU
Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update	03-07	AQ
Alpha Tau Medical : Corporate Presentation – March 2024	03-03	PU
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference	02-26	AQ
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference	12-20	GL
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference	12-20	AQ
Alpha Tau to Participate in Sidoti Small-Cap Conference	11-29	AQ
Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer	11-28	GL
Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer	11-20	GL
Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update	11-16	AQ
Alpha Tau to Participate in November Investor Conferences	11-01	AQ
Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility	30/10/23	GL
Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board	24/10/23	GL
Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board	24/10/23	AQ
Alpha Tau Medical : Notice and proxy statement for the annual general meeting of shareholders of the Company to be held on November 1, 2023 - Form 6-K	27/09/23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Alpha Tau Medical Ltd.

Equities

DRTS

IL0011839383

Press Releases

Filters